Meeder Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-162	Closed	-$10K	–	2205
2022 Q3	$10K	Sell	162 -75	-32%	-$5.24K	﹤0.01%	1340
2022 Q2	$19K	Sell	237 -206	-47%	-$19.5K	﹤0.01%	1163
2022 Q1	$47K	Sell	443 -20,208	-98%	-$1.97M	﹤0.01%	991
2021 Q4	$2.23M	Sell	20,651 -2,659	-11%	-$290K	0.22%	77
2021 Q3	$2.55M	Buy	23,310 +1,060	+5%	+$110K	0.13%	137
2021 Q2	$2.08M	Buy	22,250 +36	+0.2%	+$3.31K	0.1%	167
2021 Q1	$2.04M	Buy	22,214 +22,103	+19,913%	+$1.87M	0.1%	166
2020 Q4	$8K	Sell	111 -24,149	-100%	-$1.8M	﹤0.01%	1083
2020 Q3	$1.88M	Buy	24,260 +15,214	+168%	+$1.05M	0.12%	142
2020 Q2	$503K	Buy	9,046 +30	+0.3%	+$1.28K	0.03%	361
2020 Q1	$266K	Buy	9,016 +1,860	+26%	+$62.9K	0.02%	496
2019 Q4	$259K	Sell	7,156 -2,054	-22%	-$63K	0.02%	538
2019 Q3	$250K	Sell	9,210 -13,782	-60%	-$356K	0.02%	553
2019 Q2	$553K	Buy	22,992 +5,649	+33%	+$143K	0.04%	395
2019 Q1	$458K	Buy	17,343 +7,396	+74%	+$175K	0.04%	388
2018 Q4	$194K	Buy	9,947 +8,588	+632%	+$168K	0.02%	504
2018 Q3	$27K	Buy	1,359 +914	+205%	+$17.4K	﹤0.01%	955
2018 Q2	$7.37K	Sell	445 -196	-31%	-$2.99K	﹤0.01%	1180
2018 Q1	$9K	Buy	641 +141	+28%	+$2.08K	﹤0.01%	1110
2017 Q4	$7K	Buy	500 +320	+178%	+$4.49K	﹤0.01%	1245
2017 Q3	$2K	Sell	180 -1,093	-86%	-$13.9K	﹤0.01%	1513
2017 Q2	$15K	Buy	1,273 +820	+181%	+$10.2K	﹤0.01%	896
2017 Q1	$7K	Buy	+453	New	+$7.34K	﹤0.01%	982